Innocan Pharma Stock Price Prediction
| INNPF Stock | USD 5.76 0.16 2.70% |
Momentum 1
Sell Peaked
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of InnoCan Pharma based on different types of headlines from major news networks to social media. Using InnoCan Pharma hype-based prediction, you can estimate the value of InnoCan Pharma from the perspective of InnoCan Pharma response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in InnoCan Pharma. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in InnoCan Pharma to buy its otc stock at a price that has no basis in reality. In that case, they are not buying InnoCan because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
InnoCan Pharma after-hype prediction price | USD 5.76 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
InnoCan |
InnoCan Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of InnoCan Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in InnoCan Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of InnoCan Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
InnoCan Pharma Estimiated After-Hype Price Volatility
In the context of predicting InnoCan Pharma's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on InnoCan Pharma's historical news coverage. InnoCan Pharma's after-hype downside and upside margins for the prediction period are 0.65 and 10.87, respectively. We have considered InnoCan Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
InnoCan Pharma is relatively risky at this time. Analysis and calculation of next after-hype price of InnoCan Pharma is based on 3 months time horizon.
InnoCan Pharma OTC Stock Price Prediction Analysis
Have you ever been surprised when a price of a OTC Stock such as InnoCan Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading InnoCan Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with InnoCan Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.28 | 5.11 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
5.76 | 5.76 | 0.00 |
|
InnoCan Pharma Hype Timeline
InnoCan Pharma is currently traded for 5.76. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. InnoCan is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at -1.28%. %. The volatility of related hype on InnoCan Pharma is about 0.0%, with the expected price after the next announcement by competition of 5.76. About 28.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.03. InnoCan Pharma had not issued any dividends in recent years. Assuming the 90 days horizon the next projected press release will be uncertain. Check out InnoCan Pharma Basic Forecasting Models to cross-verify your projections.InnoCan Pharma Related Hype Analysis
Having access to credible news sources related to InnoCan Pharma's direct competition is more important than ever and may enhance your ability to predict InnoCan Pharma's future price movements. Getting to know how InnoCan Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how InnoCan Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GDNSF | Goodness Growth Holdings | 0.00 | 0 per month | 5.56 | (0.01) | 9.09 | (9.23) | 35.45 | |
| MSSTF | Mindset Pharma | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ONPPF | Oncopeptides AB | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SYMQY | SymBio Pharmaceuticals Limited | 0.00 | 0 per month | 0.00 | (0.16) | 0.00 | 0.00 | 24.71 | |
| HITC | Healthcare Integrated Technologies | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BSTG | Biostage | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EOFBY | Ecofibre Limited | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MCIOF | MCI Onehealth Technologies | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| HRPMF | Herantis Pharma Oyj | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| RTGN | RetinalGenix Technologies | 0.00 | 0 per month | 0.00 | (0.11) | 0.00 | 0.00 | 20.59 |
InnoCan Pharma Additional Predictive Modules
Most predictive techniques to examine InnoCan price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for InnoCan using various technical indicators. When you analyze InnoCan charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About InnoCan Pharma Predictive Indicators
The successful prediction of InnoCan Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as InnoCan Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of InnoCan Pharma based on analysis of InnoCan Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to InnoCan Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to InnoCan Pharma's related companies.
Story Coverage note for InnoCan Pharma
The number of cover stories for InnoCan Pharma depends on current market conditions and InnoCan Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that InnoCan Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about InnoCan Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Complementary Tools for InnoCan OTC Stock analysis
When running InnoCan Pharma's price analysis, check to measure InnoCan Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InnoCan Pharma is operating at the current time. Most of InnoCan Pharma's value examination focuses on studying past and present price action to predict the probability of InnoCan Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InnoCan Pharma's price. Additionally, you may evaluate how the addition of InnoCan Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |